Abstract: Tasteless, hydrolyzed collagen from gelatin, gelatin or animal collagenic connective tissue having an average molecular weight of from 1 to 40 kD for the preparation of agents for the treatment of osteoporosis. It may be combined with conventional agents for combatting osteoporosis, such as calcitonin, calcium salts, and/or progesterone.
Type:
Grant
Filed:
April 25, 1997
Date of Patent:
September 7, 1999
Assignee:
DGF Stoess AG
Inventors:
Adam Milan, Bernd Eggersgluss, Klaus Braumer, Reinhard Schrieber